UK's Inspiration Healthcare FY26 revenue up 24%

Inspiration Healthcare

12/02/2026 07:12

Overview

UK medical device firm says FY26 revenue rose 24% to £47.5 mln, slightly beating expectations

Adjusted EBITDA for FY26 expected to meet market consensus

Company signed multi-year purchasing agreement with major U.S. hospital network

Outlook

Company expects continued sales momentum into FY27 with a solid pipeline of opportunities

Inspiration Healthcare signed a three-year purchasing agreement with a major US hospital network

Company aims to increase recurring revenues from consumables and service

Result Drivers

STRONG H2 PERFORMANCE - Revenue in H2 increased by 10.3% year-on-year, contributing to overall FY26 growth

BACK TO BASICS STRATEGY - Improved operational execution under this strategy led to reduced net debt and a positive sales outlook

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
FY Revenue
GBP 47.50 mln


Analyst Coverage

The current average analyst rating on the shares is "strong buy" and the breakdown of recommendations is 2 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"

The average consensus recommendation for the medical equipment, supplies & distribution peer group is "buy."

Wall Street's median 12-month price target for Inspiration Healthcare Group PLC is GBp56.00, about 224.6% above its February 11 closing price of GBp17.25

Press Release: ID:nRSL6706Sa

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)